GTC
ASND icon

Ghost Tree Capital’s Ascendis Pharma A/S ASND Stock Holding History

Ghost Tree Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-185,000
Closed -$21.8M – 45
2019
Q1 		$21.8M Buy
+185,000
New +$16.2M 5.69% 3

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ghost Tree Capital's ASND Position: Q3 2024 in Review

Ghost Tree Capital reduced its Ascendis Pharma A/S (ASND) stake by 39% in Q3 2024, selling an estimated $4.62M and leaving 52,500 shares worth $7.84M. The position accounts for 2.37% of the portfolio, ranked #15.

Ghost Tree Capital first reported a position in ASND in Q2 2015 and has held it in 31 quarters since. The position peaked at $45.3M in Q1 2019. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

  • Ghost Tree Capital held 52,500 shares of Ascendis Pharma A/S worth $7.84M as of Q3 2024.
  • Ghost Tree Capital sold 34,221 Ascendis Pharma A/S shares in Q3 2024, an estimated $4.62M.
  • Ascendis Pharma A/S made up 2.37% of Ghost Tree Capital's portfolio in Q3 2024, its #15 holding.
  • Ghost Tree Capital first reported a position in Ascendis Pharma A/S in Q2 2015 and has held it in 31 quarters since.
  • Ghost Tree Capital's Ascendis Pharma A/S position peaked at $45.3M in Q1 2019.
  • 219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.